BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24185859)

  • 1. Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention.
    Little SA; Leelarathna L; Barendse SM; Walkinshaw E; Tan HK; Lubina Solomon A; de Zoysa N; Rogers H; Choudhary P; Amiel SA; Heller SR; Evans M; Flanagan D; Speight J; Shaw JA
    Diabetes Metab Res Rev; 2014 Mar; 30(3):175-90. PubMed ID: 24185859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
    Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.
    Rondags SM; de Wit M; Snoek FJ
    Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology.
    Choudhary P; Amiel SA
    Diabetologia; 2018 Apr; 61(4):761-769. PubMed ID: 29423581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorer glycaemic control in type 1 diabetes is associated with reduced self-management and poorer perceived health: a cross-sectional study.
    Ozcan S; Amiel SA; Rogers H; Choudhary P; Cox A; de Zoysa N; Hopkins D; Forbes A
    Diabetes Res Clin Pract; 2014 Oct; 106(1):35-41. PubMed ID: 25128266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
    de Galan BE; Schouwenberg BJ; Tack CJ; Smits P
    Neth J Med; 2006 Sep; 64(8):269-79. PubMed ID: 16990690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycaemia: current management and controversies.
    Choudhary P; Amiel SA
    Postgrad Med J; 2011 Apr; 87(1026):298-306. PubMed ID: 21296797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycaemia and its management in primary care setting.
    Ibrahim M; Baker J; Cahn A; Eckel RH; El Sayed NA; Fischl AH; Gaede P; Leslie RD; Pieralice S; Tuccinardi D; Pozzilli P; Richelsen B; Roitman E; Standl E; Toledano Y; Tuomilehto J; Weber SL; Umpierrez GE
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3332. PubMed ID: 32343474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes.
    Hermanns N; Kulzer B; Kubiak T; Krichbaum M; Haak T
    Diabetes Metab Res Rev; 2007 Oct; 23(7):528-38. PubMed ID: 17245692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ; Zrebiec J
    Diabetes Metab Res Rev; 2008; 24(4):257-85. PubMed ID: 18232062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind clinical and laboratory study of hypoglycaemia with human and porcine insulin in diabetic patients reporting hypoglycaemia unawareness after transferring to human insulin.
    Maran A; Lomas J; Archibald H; Macdonald IA; Gale EA; Amiel SA
    BMJ; 1993 Jan; 306(6871):167-71. PubMed ID: 8443479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with Type 1 diabetes: the association with diabetes duration.
    Olsen SE; Asvold BO; Frier BM; Aune SE; Hansen LI; Bjørgaas MR
    Diabet Med; 2014 Oct; 31(10):1210-7. PubMed ID: 24824356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
    Agesen RM; Alibegovic AC; Andersen HU; Beck-Nielsen H; Gustenhoff P; Hansen TK; Hedetoft C; Jensen T; Juhl CB; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    BMC Endocr Disord; 2019 Jul; 19(1):78. PubMed ID: 31337371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
    Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.